P57 PRE‐EXPOSURE PROPHYLAXIS FOR COVID‐19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA
Ntanasis‐Stathopoulos, I., Gavriatopoulou, M., Eleutherakis‐Papaiakovou, E., Malandrakis, P., Spiliopoulou, V., Syrigou, R.E., Theodorakakou, F., Fotiou, D., Migkou, M., Roussou, M., Kastritis, E., Dimopoulos, M.A., Terpos, E.
Published in HemaSphere (09.05.2023)
Published in HemaSphere (09.05.2023)
Get full text
Journal Article
P54 ORAL ANTIVIRALS RITONAVIR‐NIRMATRELVIR AND MOLNUPIRAVIR ARE HIGHLY EFFECTIVE IN PATIENTS WITH MULTIPLE MYELOMA AND COVID‐19; A SINGLE‐CENTER, PROSPECTIVE STUDY
Spiliopoulou, V., Ntanasis‐Stathopoulos, I., Malandrakis, P., Gavriatopoulou, M., Theodorakakou, F., Fotiou, D., Syrigou, R. E., Migkou, M., Roussou, M., Eleutherakis‐Papaiakovou, E., Kastritis, E., Dimopoulos, M. A, Terpos, E.
Published in HemaSphere (09.05.2023)
Published in HemaSphere (09.05.2023)
Get full text
Journal Article
B06 HIGH LEVELS OF CIRCULATING PLASMA CELLS AT DIAGNOSIS ARE PREDICTIVE FOR WORSE PROGNOSIS IN BOTH TRANSPLANT‐ELIGIBLE AND ‐INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA
Malandrakis, P., Ntanasis‐Stathopoulos, I., Kostopoulos, I.V., Roussakis, P., Eleutherakis‐Papaiakovou, E., Panteli, C., Angelis, N., Spiliopoulou, V., Orologas‐Stavrou, N., Theodorakakou, F., Fotiou, D., Migkou, M., Gavriatopoulou, M., Kastritis, E., Tsitsilonis, O.E., Dimopoulos, M.A., Terpos, E.
Published in HemaSphere (09.05.2023)
Published in HemaSphere (09.05.2023)
Get full text
Journal Article
P14 OCULAR TOXICITY IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH BELANTAMAB MAFODOTIN, LENALIDOMIDE AND DEXAMETHASONE IN A PHASE 1/2 TRIAL
Ntanasis‐Stathopoulos, I., Gavriatopoulou, M., Malandrakis, P., Fotiou, D., Kanellias, N., Migkou, M., Theodorakakou, F., Spiliopoulou, V., Syrigou, R., Eleutherakis‐Papaiakovou, E., Gkolfinopoulos, S., Manousou, K., Kastritis, E., Dimopoulos, M.A., Terpos, E.
Published in HemaSphere (09.05.2023)
Published in HemaSphere (09.05.2023)
Get full text
Journal Article
828P Translocation 11;14 is not associated with adverse prognosis in the era of novel anti-myeloma therapeutics
Ntanasis-Stathopoulos, I., Malandrakis, P., Spiliopoulou, V., Briasoulis, A., Fotiou, D., Migkou, M.D., Theodorakakou, F., Kanellias, N., Eleutherakis-Papaiakovou, E., Roussou, M., Kastritis, E., Terpos, E., Dimopoulos, M.A.C., Gavriatopoulou, M.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
820P Second primary malignancies and disease transformation in symptomatic patients with Waldenstrom’s macroglobulinemia: Outcomes of a population-based analysis
Spiliopoulou, V., Ntanasis-Stathopoulos, I., Kyrtsonis, M-C., Symeonidis, A., Hatjiharissi, E., Giannakoulas, N., Spanoudakis, E.G., Delimpasi, S., Michali, E., Michael, M.D., Vassou, A., Iskas, M., Pouli, A., Vervessou, E., Christoulas, D., Katodritou, E., Terpos, E., Kastritis, E., Dimopoulos, M.A.C., Gavriatopoulou, M.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article